长非编码RNAs在瘤干:新出现的机制和治疗机会
Eduardo Moraes Reis1, Daniela Sanchez Bassères1
1Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brazil.
Frontiers in genetics
|March 13, 2026
概括
长非编码RNAs (lncRNAs) 通过影响基因表达来调节癌症干细胞 (CSC) 生物学. 了解这些lncRNAs为抗击瘤可塑性和耐药性提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 癌症干细胞 (CSCs) 驱动瘤的进展,转移和治疗抵抗.
- 维持CSCs的表观遗传机制是复杂的,并未完全理解.
- 长非编码RNAs (lncRNAs) 是基因表达的新兴调节者,在细胞可塑性和干性中发挥作用.
研究的目的:
- 审查目前对 lncRNAs 如何调节癌症干细胞生物学的理解.
- 为了分类 lncRNAs 影响 CSC 表型的机制.
- 讨论先进的奥米克技术和基于 lncRNA 的治疗方法的影响.
主要方法:
- 关于lncRNAs和CSCs当前发现的文献综述.
- lncRNA调节机制的分类 (表观遗传,转录,转录后).
- 讨论高分辨率奥米克 (批量,单细胞,空间转录) 和治疗策略.
主要成果:
- lncRNAs在CSC自我更新,分化,瘤发生性和耐药性中发挥着关键作用.
- 机制包括染色体重塑和调节mRNA/蛋白质稳定性.
- 先进的奥米学正在识别新的CSC相关的lncRNA和潜在的生物标志物.
结论:
- lncRNAs是CSC可塑性和治疗耐药性的关键调节者.
- 高分辨率的奥米克对于发现CSC特定的lncRNAs至关重要.
- lncRNA导向的疗法为癌症治疗提供了一个有前途的途径.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
02:39lncRNA - Long Non-coding RNAs
3.8K
3.8K
02:40Cancer Stem Cells and Tumor Maintenance
6.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
02:40Cancer Stem Cells and Tumor Maintenance
2.3K
2.3K
03:03mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
03:03mTOR Signaling and Cancer Progression
1.6K
1.6K